Immune Tolerance Network   A clinical research consortium sponsored by NIAID and JDRF
START logoA clinical research study of thymoglobulin to arrest type 1 diabetes


Contact Us

Recruitment for the START study is now closed.

For information on additional ITN trials for people recently diagnosed with type 1 diabetes, please visit:

Retain Study

T1DAL Study

Terms of Use | Privacy | Accessibility
©2007, Immune Tolerance Network